Next Gen Bioengineers Partnership Of Eth Zurich And Roche Department Advancing the development and application of bioengineering for translational medicine and potential therapies. a partnership between eth zurich and roche: fostering the next generation of researchers in translational bioengineering to push the boundaries of today’s medicine. To spearhead this translational medicine revolution, eth zurich and roche joined forces and provide one of the best learning and research environments in academia and the pharmaceutical industry for scientists in a joint doctoral or postdoctoral programme.
Homepage Next Gen Bioengineers Eth Zurich The recent scientific retreat for the eth zurich roche partnership, next gen bioengineers, brought together a dynamic mix of researchers, scientists, programme sponsors, and distinguished guests to foster innovation and collaboration and reflect on the successful first year of the programmes. In collaboration with partners from industry, hospitals and other academic institutions, the basel location facilitates research applications in the emerging fields of precision medicine and personalised health, molecular systems engineering and data science. Launched by the eth department of biosystems science and engineering (d bsse) and the roche institute of human biology, this joint programme trains doctoral researchers in projects related to human model systems and biosystems engineering for translation. Fostering the next generation of researchers in translational bioengineering, eth zurich and roche have joined forces to advance the development and application of new methods in bioengineering for translational medicine and potential therapies.
Homepage Next Gen Bioengineers Eth Zurich Launched by the eth department of biosystems science and engineering (d bsse) and the roche institute of human biology, this joint programme trains doctoral researchers in projects related to human model systems and biosystems engineering for translation. Fostering the next generation of researchers in translational bioengineering, eth zurich and roche have joined forces to advance the development and application of new methods in bioengineering for translational medicine and potential therapies. Co supervised by experts from both institutions in basel, doctoral students work on translational models and tools in gene , cell and organoid based therapies to meet the real world challenges in translational medicine. research projects take approximately four years. D bsse also maintains close ties with regional chemical and pharmaceutical industry partners. the next gen bioengineers partnership between eth zurich and roche, aims to advance the development of new methods that facilitate the search for medicines. Operated through the next gen bioengineers partnership, the programme connects eth zurich (d bsse) with roche pharma research and early development (pred). The recent scientific retreat for the eth zurich roche partnership, next gen bioengineers, brought together a dynamic mix of researchers, scientists, programme sponsors, and distinguished guests to foster innovation and collaboration and reflect on the successful first year of the programmes.
Comments are closed.